RNS Number : 7862I
Gunsynd PLC
28 March 2024
 

Gunsynd PLC

("Gunsynd" or the "Company")

Issue of Equity

Gunsynd (AIM: GUN; AQSE: GUN) announces that it has issued 17,000,000 new ordinary shares to settle a liability to the value of £24,000 ("Fee Shares").

Admission

 

Application will be made to the London Stock Exchange to admit the Fee Shares to trading on AIM and to the Aquis Stock Exchange Growth Market ("Admission"). Admission of the new ordinary shares is expected to occur on or around 5 April 2024. The Fee Shares will rank pari passu with the existing ordinary shares.

 

Total Voting Rights

For the purpose of the Disclosure and Transparency Rules, following Admission, the enlarged issued share capital of the Company will comprise 571,796,506 ordinary shares of 0.085p each. The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure and Transparency Rules.

This announcement contains inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.

For further information please contact:

 

Gunsynd plc

Hamish Harris/ Peter Ruse

 www.gunsynd.com

 

 

+44 (0)7879 584 153

Cairn Financial Advisers LLP

James Caithie / Liam Murray

 

+44 (0)20 7213 0880

 

Peterhouse Capital Limited

Lucy Williams

 

+44 (0)20 7469 0936

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEBLGDXGGDDGSI